Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double blind, placebo-controlled, superiority clinical trial
was to assess clinical efficacy of antazoline in rapid conversion of atrial fibrillation
during observation sinus rhythm.